Contents

Search

ABT-450

Indications: - hepatitis C infection - used in combination with ritonavir, ombitasvir, dasabuvir & ribavirin Dosage: - ABT-450 150 mg, ritonavir 100 mg, ombitasvir 25 mg QD, dasabuvir 250 mg BID, & ribavirin adjusted to body weight for 12-24 weeks

General

antiviral protease inhibitor

References

  1. Poordad F et al ABT-450/r - Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis. N Engl J Med. April 12, 2014 PMID: 24725237 http://www.nejm.org/doi/full/10.1056/NEJMoa1402869